Bristol-Myers says guidance assumes R&D credit will be extended Says Reyataz seeing increased competitive pressure. Says business development a top priority for capital allocation. Comments made on the Q2 earnings conference call.
News For BMY From The Last 14 Days
Check below for free stories on BMY the last two weeks.